Abstract
With interest we read the letter by Swedberg et al .1 in which they investigated the effects of beta-blockers in patients with chronic heart failure who also had atrial fibrillation, in the Carvedilol or Metoprolol European Trial (COMET). The authors compared treatment with carvedilol 25 mg …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
